How Swaminathan was paid
$2.1M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Options | Total |
|---|---|---|---|---|
| Arun SwaminathanChief Executive Officer, Director | $546,000 | $395,850 | $1,149,157 | $2,091,007 |
| Howard BermanFormer Chief Executive Officer, Former Executive Chairman of the Board | $436,800 | $316,680 | $718,221 | $1,471,701 |
| David SnyderChief Financial Officer and Chief Operating Officer | $442,000 | $256,360 | $670,340 | $1,368,700 |
| Fred GrossmanPresident, Chief Medical Officer | $498,160 | $288,933 | $670,340 | $1,457,433 |
What changed and why
- $2.1M$2.1 million was CEO Arun Swaminathan’s total compensation in 2025, up from $1.5 million in 2024.
- $1.1M$1.1 million of Swaminathan’s 2025 compensation consisted of stock option awards.
- $396K$395,850 was Swaminathan’s 2025 bonus, compared with $185,417 in 2024.
- $1.5M$1.5 million was former Executive Chairman Howard Berman’s total compensation in 2025.
- 50%50% of base salary was the annual bonus target for Swaminathan and Berman.
- 40%40% of base salary was the annual bonus target for Snyder and Grossman.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.